Clinical Trials Sponsored by Alberto Pilotto

Total 2166 results

AHS Cancer Control Alberta

Not yet recruiting

A Phase II Trial of iTTo in Advanced Gastric and GEJ Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Carcinoma

Canada
AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients

Glioblastoma Multiforme

Canada
AHS Cancer Control Alberta

Recruiting

Pre- Versus Post-operative SRS for Resectable Brain Metastases

Brain Metastases

Canada
Alberta Health Services, Calgary

Recruiting

Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis

Septic Shock

Canada
AHS Cancer Control Alberta

Recruiting

HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis (ATG2017)

Relapse | Graft-versus-host-disease

Canada
AHS Cancer Control Alberta

Recruiting

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Carcinoma, Neuroendocrine

Canada
University of Alberta
Pfizer

Active, not recruiting

Management of LUTS by Community Pharmacists

Lower Urinary Tract Symptoms

Canada
University of Alberta
Mitacs

Completed

Intraoral Ultrasound Imaging of Tooth-periodontium Complex

Periodontitis | Alveolar Bone Loss

Canada
AHS Cancer Control Alberta

Terminated

Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate (PREMIUM)

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta

Completed

Multi-Parametric Brain Cancer MRI

Brain Tumors

Canada
AHS Cancer Control Alberta

Completed

A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland (PET PRO)

Prostatic Neoplasms

Canada
Alberta Health Services, Calgary

Completed

Guided Occupational Therapist Cognitive Interventions in Critically Ill Patients (GOTCI)

Delirium

Canada
Alberta Health Services, Calgary

Unknown

Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow

Non-Hodgkin Lymphoma

Canada
AHS Cancer Control Alberta

Terminated

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

Colon Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib

Fatigue | Renal Cell Cancer

Canada
AHS Cancer Control Alberta

Terminated

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy (CIPN)

Peripheral Neuropathy in Breast Cancer Patient

Canada
AHS Cancer Control Alberta

Withdrawn

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Hypoxic Tumours
AHS Cancer Control Alberta

Completed

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

Lung Neoplasms | Lung Cancer

Canada
AHS Cancer Control Alberta

Unknown

A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely

Neoplasm Metastasis | Colonic Neoplasms
AHS Cancer Control Alberta

Unknown

Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients (CHIRP)

High-risk Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Breast Cancer

Canada
AHS Cancer Control Alberta

Unknown

Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology

Glioma

Canada
AHS Cancer Control Alberta

Completed

Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors

Colonic Neoplasms

Canada
AHS Cancer Control Alberta

Completed

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

Glioma

Canada
AHS Cancer Control Alberta

Terminated

Blood Test to Measure DNA Damage in Blood

Prostate Cancer

Canada
AHS Cancer Control Alberta

Terminated

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Gastric Cancer | Esophageal Cancer | Tumors

Canada
University of Alberta
3M

Withdrawn

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study

Morphea

Canada
AHS Cancer Control Alberta

Unknown

Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone

Bone Scan

Canada
AHS Cancer Control Alberta

Unknown

Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

Glioma

Canada
AHS Cancer Control Alberta

Completed

Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients

Seminoma | Testicular Cancer | Non-seminomatous

Canada
AHS Cancer Control Alberta

Terminated

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Metastatic Breast Cancer

Canada
University of Alberta
Sanofi

Completed

Pharmacist Intervention for Glycemic Control in The Community (RxING)

Type 2 Diabetes

Canada
University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Health services; Alberta... and other collaborators

Enrolling by invitation

BedMed-Frail: Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations?

Hypertension | Dementia

Canada
Albireo

Recruiting

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

Biliary Atresia

Netherlands, United States, Spain, Italy, Taiwan, Korea, Republic of, France, Germany, United Kingdom, Canada, Belgium, China, Australia, Poland, Turkey, Malaysia, New Zealand, Hungary, Israel
Albireo

Enrolling by invitation

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia (BOLD-EXT)

Biliary Atresia

Spain, United States, Netherlands, Malaysia, Canada, Germany, Turkey, Italy, France, Australia, Poland, New Zealand
Albireo

Active, not recruiting

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Progressive Familial Intrahepatic Cholestasis

United States, Spain, Netherlands, United Kingdom, Turkey, Canada, Italy, Germany, France, Israel, Australia, Belgium, Poland, Saudi Arabia, Sweden
Albireo

Completed

Study of A3309 in Patients With Dyslipidemia

Dyslipidemia

Sweden
Albireo

Completed

Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome (ASSERT)

Alagille Syndrome

United States, United Kingdom, France, Germany, Canada, Netherlands, Italy, Malaysia, Belgium, Israel, New Zealand, Poland, Turkey
Albireo

Recruiting

Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

Spain, Italy, France
Albireo

Active, not recruiting

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome (ASSERT-EXT)

Alagille Syndrome

United Kingdom, United States, France, Germany, Netherlands, Italy, Belgium, Malaysia, Poland, Turkey
Albireo

Completed

An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects

Primary Biliary Cirrhosis | Alagille Syndrome | Progressive Familial Intrahepatic Cholestasis | Orphan Cholestatic Liver Diseases

United Kingdom
Albireo

Completed

A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384

Primary Biliary Cirrhosis | Alagille Syndrome | Progressive Familial Intrahepatic Cholestasis | Orphan Cholestatic Liver Diseases
Institute of Health Economics, Canada
Alberta Health services; University of Alberta; Alberta Innovates Health Solutions and other collaborators

Unknown

Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of Technology

Alcoholism | Pregnancy
Hospital Israelita Albert Einstein

Recruiting

Gestrinone and Endothelial Function in Young Women

Cardiovascular Diseases | Hormones; Abuse

Brazil
Hospital Israelita Albert Einstein

Not yet recruiting

Evaluation of the Impact of Rehabilitation Strategies and Early Discharge After Respiratory Failure (Rehab)

Acute Respiratory Failure
Hospital Israelita Albert Einstein

Recruiting

Platelet Sub-study of the Neomindset Trial

Acute Coronary Syndrome

Brazil
Hospital Israelita Albert Einstein

Recruiting

Telemedicine and Face-to-face Consultations Diagnostic Accuracy Comparison in Orthopedic Patients

Orthopedic Patients

Brazil
Hospital Israelita Albert Einstein

Recruiting

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial (NEOMINDSET)

Acute Coronary Syndrome

Brazil
Albert Einstein Healthcare Network

Recruiting

Cesarean Section Skin Prep - Does Skin Preparation Pattern Affect Skin Bacterial Burden

Cesarean Section Complications | Wound Infection

United States

3

Subscribe